Endothelial growth medium suppresses apoptosis of mesenchymal stem cells in vitro via decrease of miR‑29a.

Area of Science:

• Cardiovascular biology
• Stem cell therapy
• Regenerative medicine

Background:

• Mesenchymal stem cells (MSCs) show promise in treating cardiac ischemia/reperfusion injury (IRI).
• A key limitation is the poor survival rate of transplanted MSCs.
• Enhancing MSC survival is crucial for effective cardiac repair therapies.

Purpose of the Study:

• To investigate the survival mechanisms of human amnion-derived mesenchymal stem cells (hAMSCs) under stress conditions.
• To determine the role of endothelial growth medium (EGM-2) in hAMSC survival.
• To elucidate the involvement of microRNA-29a (miR-29a) and MCL-1 in hAMSC survival.

Main Methods:

• Culturing hAMSCs with EGM-2 under serum-free and hypoxic conditions.
• Assessing hAMSC apoptosis rates.
• Analyzing the expression levels of miR-29a and MCL-1 (mRNA and protein).
• Performing miR-29a knockdown experiments.

Main Results:

• EGM-2 culture reduced apoptosis in hAMSCs exposed to serum-free and hypoxic conditions.
• miR-29a expression significantly decreased under these stress conditions.
• miR-29a knockdown further decreased apoptosis and increased MCL-1 expression.
• EGM-2 promotes hAMSC survival via miR-29a and MCL-1 regulation.

Conclusions:

• EGM-2 enhances hAMSC survival under stress conditions relevant to cardiac IRI.
• The miR-29a/MCL-1 axis is a key mechanism mediating EGM-2's protective effect.
• These findings suggest a potential therapeutic strategy for improving MSC engraftment in cardiac IRI treatment.